Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is issuing a voluntary recall of one lot of Veklury® (remdesivir) for Injection 100 mg/vial, to the consumer level. Gilead received a customer c ...
A small study of 156 people with COVID-19 has found that mutations that confer resistance to antiviral drugs were “commonly detected”, especially in immunocompromised patients. The authors stress that ...
The FDA has extended the emergency use authorisation for Gilead Sciences' antiviral Veklury to include non-hospitalised patients with COVID-19, extending the uses of the drug. The green light ...